Program

Mansoor Ahmed, NCI, NIH
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University

Mansoor Ahmed, NCI, NIH, Welcome/Introduction to the Guest Symposium
Gayle E. Woloschak, Northwestern University, Introduction: Information on Radiation Research Society (RRS)
Ralph R. Weichselbaum, University of Chicago Medicine, Basic radiation biology: fatal attraction for immunologists
Yang-Xin Fu, University of Chicago, Immunologist's experiences of collaborating with the field of radiation biology
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University, Opportunities for immunology in clinical radiotherapy
Fernando Macian-Juan, Albert Einstein College of Medicine of Yeshiva University, Use of focused ultrasound to prevent immune escape

Irah L. King, McGill University
Jude E. Uzonna, University of Manitoba

Jun Wang, Dalhousie University, Diverse immune mechanisms for shaping anti-Chlamydia CD4 T cell responses
Simona Stäger, INRS-Institut Armand Frappier, The role of inflammation in regulating the development of T cell responses during leishmaniasis
Irah L. King, McGill University, The role of integrins in T follicular helper cell maintenance following helminth infection
S. M. Mansour Haeryfar, University of Western Ontario, Invariant T cell responses to bacterial superantigens
Jude E. Uzonna, University of Manitoba, MHC class II-restricted innate-like double negative T cells display memory characteristics and contribute to optimal anti-Leishmania immunity

Mansoor Ahmed, NCI, NIH
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University

Mansoor Ahmed, NCI, NIH, Welcome/Introduction to the Guest Symposium
Gayle E. Woloschak, Northwestern University, Introduction: Information on Radiation Research Society (RRS)
Ralph R. Weichselbaum, University of Chicago Medicine, Basic radiation biology: fatal attraction for immunologists
Yang-Xin Fu, University of Chicago, Immunologist's experiences of collaborating with the field of radiation biology
Chandan Guha, Albert Einstein College of Medicine of Yeshiva University, Opportunities for immunology in clinical radiotherapy
Fernando Macian-Juan, Albert Einstein College of Medicine of Yeshiva University, Use of focused ultrasound to prevent immune escape

Eric Meffre, Yale University
Jane Hoyt Buckner, Benaroya Research Institute at Virginia Mason

Eric Meffre, Yale University, Defects in early B cell tolerance checkpoints are common to autoimmune diseases
Jane Hoyt Buckner, Benaroya Research Institute at Virginia Mason, Mapping the immune pathways that drive T1D development
Megan Sykes, Columbia University, New approaches to understanding human allo- and autoimmune responses
Erik J. Peterson, University of Minnesota, PTPN22 promotes interferogenic signaling in myeloid cells
Edward K. Wakeland, University of Texas Southwestern Medical Center, A genomic analysis of systemic autoimmunity
Judith A. James, Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Roles for impaired immune regulation in transition from preclinical autoimmunity to clinical lupus

Michael L. Dustin, University of Oxford
Janis K. Burkhardt, Children's Hospital of Philadelphia and University of Pennsylvania

Michael L. Dustin, University of Oxford, Novel signals in the immunological synapse
Janis K. Burkhardt, Children's Hospital of Philadelphia/University of Pennsylvania, Cytoskeletal control of integrin activation at the immunological synapse
Morgan Huse, Memorial Sloan Kettering Cancer Center, Lipid-based patterning of the immunological synapse
Clotilde Théry, INSERM U932 / Institut Curie, Exosomes and other extracellular vesicles in communication between tumors and the immune system
Anna Huttenlocher, University of Wisconsin, Imaging inflammation: implications to human disease
Thorsten R. Mempel, Massachusetts General Hospital/Harvard Medical School, Immune cell communication in the tumor environment

Booki Min, Cleveland Clinic Foundation
Chong-Kil Lee, Chungbuk National University

Woong-Kyung Suh, Clinical Research Institute of Montreal, Dissection of inducible costimulator (ICOS) signaling components in follicular helper T cell and Th17 responses
Eun Young Choi, Seoul National University, CD8 T cells can generate memory cells without CD4 help when antigen is cleared early enough
Sang-Moo Kang, Georgia State University, Roles of innate and adaptive immune components in inducing protective immune responses to influenza vaccination
Myoung Ho Jang, Institute for Basic Science, Pohang, Eosinophils regulate inflammation in the gut

Louis B. Justement, University of Alabama at Birmingham
Silvia M. Uriarte, University of Louisville

Joshua J. Obar, Montana State University, Leukotriene and IL-1alpha-mediated orchestration of the antifungal leukocyte response to Aspergillus fumigatus
I. Coy Allen, Virginia Polytechnic Institute and State University, Evaluating NLR modulation of canonical and non-canonical NF-κB signaling in IBD
Laura M. Sly, University of British Columbia, Harnessing macrophage phenotype for anti-inflammatory therapy
Madhavi J. Rane, University of Louisville, Baclofen, a GABA_BR agonist, ameliorates immune-complex-mediated acute lung injury by modulating pro-inflammatory mediators
Ilhem Messaoudi Powers, University of California, Riverside, Dose-dependent modulation of immune response to vaccination by alcohol
Silvia M. Uriarte, University of Louisville, Neutrophils and oral pathogens: opposing forces in the dysbiosis battle

Virginia Shapiro, Mayo Clinic, AAI Committee on the Status of Women Chair

James Gould, Director, Office for Postdoctoral Fellows, Harvard Medical School

Cherié L. Butts, Biogen-Idec; AAI Minority Affairs Committee Chair

Gabriel Núñez, University of Michigan, Linking pathogen virulence, immunity, and the microbiota

Linda A. Sherman, Scripps Research Institute, AAI President

Derek Haseltine, Director, Career Services, College of Professional Studies, George Washington University

Robert L. Modlin, UCLA
Angela Colmone, Science Translational Medicine, AAAS

Alan Sher, NIAID, NIH, A host-directed therapy for TB infection that targets innate cytokines
Hana Golding, CBER FDA, Novel methods for measuring antibody affinity, epitope diversity, and cross-reactivity in human vaccine trials
Drew M. Pardoll, Johns Hopkins School of Medicine, Therapeutic manipulation of the microenvironment of cancer
Jeffrey A. Bluestone, University of California, San Francisco, Rebalancing the immune system through Treg biology
Angela Colmone, Science Translational Medicine, AAAS, Translational immunology research: into the future

Hans-Martin Jäck, University of Erlangen
Dieter Kabelitz, University of Kiel
Carsten Watzl, Leibniz Research Center, Dortmund

Jürgen Wienands, University of Göttingen, Immunology in Germany
Tim Sparwasser, University of Hannover, Metabolic influences that regulate CD4 T cell function
Vigo Heissmeyer, University of Munich, Post-transcriptional control of Th17 differentiation
Petra Hoffmann, University of Regensburg, Impact of Treg cell plasticity on adoptive cell therapies
Jochen Hühn, Helmholtz Society, Braunschweig, Epigenetic control of regulatory T cell development
Michael Lohoff, University of Marburg, The role of interferon regulatory factors for T cell subset differentiation

Linda A. Sherman, Scripps Research Institute, AAI President